Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 18, 2022 - Issue
Submit an article Journal homepage
219
Views
5
CrossRef citations to date
0
Altmetric
Review

An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives

Romain Iaxx1 Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France
,
Felix Lefort1 Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France;2 Bordeaux University, Bordeaux, France
,
Charlotte Domblides1 Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France;2 Bordeaux University, Bordeaux, France;3 ImmunoConcEpt, CNRS UMR 5164, Bordeaux University, Bordeaux, 33076, France
,
Alain Ravaud1 Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France;2 Bordeaux University, Bordeaux, FranceORCID Iconhttps://orcid.org/0000-0001-9455-6744
ORCID Icon,
Jean-Christophe Bernhard2 Bordeaux University, Bordeaux, France;4 Department of Urology, Hôpital Pellegrin, Bordeaux University Hospital, Bordeaux, France
&
Marine Gross-Goupil1 Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, FranceCorrespondence[email protected]
Pages 619-632 | Published online: 02 Jun 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (5)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.